市场调查报告书
商品编码
1471241
放射治疗设备市场:按类型、应用和最终用户划分 - 全球预测 2024-2030Radiation Therapy Equipment Market by Type (External Beam Radiotherapy, Internal Beam Radiotherapy), Application (Cancer, Non-cancer), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年放射治疗设备市场规模为77.6亿美元,预计2024年将达82.8亿美元,2030年将达到125.5亿美元,复合年增长率为7.11%。
放射治疗设备是一种利用放射线治疗癌症和其他疾病的医疗设备。放射治疗可以精确地瞄准肿瘤,同时最大限度地减少对附近健康组织的损害。放射治疗机通常高功率,可以提供不同的剂量水平,使医生能够为每位患者量身定制治疗计划。癌症的普及和外科手术的日益普及是推动对先进放射治疗设备的需求的主要因素。各国政府采取了多项倡议来扩大癌症治疗的覆盖范围,保险报销的改善使更多的患者能够接受治疗。然而,政府对设备核准的严格规定阻碍了许多经济体的设备普及。市场相关人员一直致力于透过数位化和自动化来提高放射治疗设备的操作能力,同时保持最大程度的品管,以确保产品核可。此外,公共和私人对癌症治疗研究和开发的投资正在迅速增加,预计将加速新治疗设备的开发。
主要市场统计 | |
---|---|
基准年[2023] | 77.6亿美元 |
预测年份 [2024] | 82.8亿美元 |
预测年份 [2030] | 125.5亿美元 |
复合年增长率(%) | 7.11% |
粒子束治疗系统的进步使得更精确的放射治疗成为可能。
外部放射治疗 (EBRT) 是一种非侵入性方法,可从体外向肿瘤提供高剂量的放射线。传统的钴60远端医疗装置是最早用于癌症治疗的体外放射治疗装置之一。该设备使用放射性钴 60 源发射的伽马射线来破坏癌组织。线性加速器,称为直线加速器,是外部放射治疗的现代形式。线性加速器向患者的肿瘤区域发送高能量 X 光和电子束。这些设备用途极为广泛,并且可以实现相当高的精度和控制,因为剂量可以根据肿瘤的3D形状进行调整。粒子治疗系统是外束放射治疗的尖端和先进子集,它使用质子和重离子等粒子代替 X 射线来治疗癌症。这些系统,包括质子疗法和碳离子疗法,利用了称为布拉格峰的独特物理优势,在粒子在组织中静止之前发生最大能量释放,从而可以精确地传递辐射。内束放射治疗将放射源放置在肿瘤本身内部或附近。当肿瘤部位需要直接接受高剂量辐射时,这种类型的治疗是必要的,并且通常用于治疗前列腺癌、子宫颈癌和乳腺癌等疾病。后荷机在近距离放射治疗(一种体内放射治疗)中发挥着至关重要的作用。这种先进的设备可以将放射源精确地放置在需要治疗的组织内或附近,同时最大限度地减少医务人员的辐射暴露。施用器是近距离放射治疗中用于将放射源放置在治疗区域的重要仪器。这些设备有各种形状和尺寸,并针对特定的身体部位和治疗方案量身定制。术中放射治疗系统是用于在手术期间向肿瘤部位输送放射线的最先进的设备。 IORT系统可以在切除肿瘤后直接进行放射治疗,同时暂时转移和保护周围的健康组织。种子是指用于近距离放射治疗的小型放射性植入,称为种子植入。这些种子被直接植入前列腺并持续发射辐射,但剂量会随着时间的推移而减少,以破坏癌细胞。
应用范例乳癌盛行率的增加正在推动放射治疗设备的引入。
在治疗淋巴瘤、白血病和骨髓瘤等血癌时,放射线治疗可用于破坏骨髓、脾臟和其他疾病扩散区域的癌细胞。在干细胞移植之前也会进行放射线治疗,以使身体为新的造血细胞做好准备。放射线治疗是乳癌治疗的主要手段。它用于破坏手术后乳房、胸壁和腋窝中剩余的癌细胞。在某些情况下,它可以在手术前用于缩小肿瘤或安宁疗护以缓解晚期癌症的症状。放射线治疗可用于外用和内用治疗胃肠道癌症,如胃癌、结肠癌、直肠癌和胰腺癌。它通常在手术前用于缩小肿瘤,并在手术后用于靶向剩余的癌细胞。在安宁疗护中缓解疼痛、出血和阻塞也很重要。摄护腺癌的放射线治疗包括体外放射治疗和近距离放射治疗。放射线治疗可用作主要治疗或手术后治疗残留癌症。影像导引放射线治疗(IGRT) 和调调变放射线治疗(IMRT) 等先进技术可实现更精确的放射标靶并最大限度地减少对周围组织的损伤。对于肺癌和其他呼吸道癌症,放射线治疗可以作为主要治疗方法或与其他治疗方法结合。它对小细胞肺癌和非小细胞肺癌的治疗有效,特别是对于无法接受手术的患者。立体定位放射线治疗是一种先进的放射治疗形式,可为较小的肺部肿瘤提供精准治疗。放射线治疗可用于治疗鳞状细胞癌和基底细胞癌(一种皮肤癌)。放射线治疗是一种非侵入性治疗方法,当不首选手术或其他健康问题导致手术有危险时,可以考虑放射治疗。放射线治疗可能是一种根治性治疗方法,也可能用于缓解晚期癌症的症状。在非癌症应用中,放射治疗机用于治疗良性疾病,例如甲状腺毒症和某些发炎疾病。在非癌症治疗中对放射线治疗的偏好是基于其标靶作用,并且在某些情况下,其能够提供手术和药物治疗的非侵入性替代方案。
最终用户:由于患者数量庞大,医院优先考虑多功能、高通量系统。
放射治疗设备最大的最终使用者群体是医院。患者通常需要广泛的放射治疗解决方案来满足他们的多样化需求。医院安装了各种类型的放射治疗设备,包括直线加速器、质子治疗系统和近距离放射治疗系统,以提供全面的癌症治疗服务。专科诊所通常专注于治疗特定的癌症类型,因此需要根据其特定需求量身定制的专门放射治疗设备。这些诊所喜欢经过优化以治疗特定癌症类型的设备,对于小型患者群体来说具有成本效益,并且可以轻鬆整合到小型临床环境中。
区域洞察
美洲地区是放射治疗设备的已开发市场,并得到了提供高度自动化设备和发达的癌症护理基础设施的老牌公司的支持。在美国和加拿大,癌症治疗的保险报销范围扩大,使患者能够使用各种设备接受高品质的治疗。亚太地区癌症患者盛行率较高,医疗机构不断进行研发以开发需要新设备的改良治疗方法。欧洲地区拥有一些在提供放射治疗设备方面拥有多年经验的知名公司。政府针对癌症治疗采取了多项措施和宣传计划,增加了患者对早期手术的偏好。欧洲医疗机构和美国食品药物管理局为放射治疗设备的核准和销售提供严格的指导方针。然而,近年来,一些公司已开始在这些国家获得商业化批准,作为癌症治疗的必需产品。
FPNV定位矩阵
FPNV定位矩阵对于评估放射治疗设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对放射治疗设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.放射治疗设备市场的市场规模与预测为何?
2.在放射治疗设备市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.放射治疗设备市场的技术趋势和法规结构是什么?
4.放射治疗设备市场主要厂商的市场占有率?
5.进入放射治疗设备市场的合适型态和策略手段是什么?
[183 Pages Report] The Radiation Therapy Equipment Market size was estimated at USD 7.76 billion in 2023 and expected to reach USD 8.28 billion in 2024, at a CAGR 7.11% to reach USD 12.55 billion by 2030.
Radiation therapy equipment is a type of medical equipment used to treat cancer and other conditions with radiation. Radiation therapy has the ability to precisely target tumors while minimizing injury to nearby healthy tissue. Radiation therapy equipment is mostly of high power and has the ability to deliver different dose levels, allowing doctors to customize treatment plans for each patient. The prevalence of cancer and the increasing adoption of surgical procedures have been the major factors driving the need for advanced radiotherapy equipment. Governments have taken multiple initiatives to expand access to cancer treatment, and improved reimbursement coverage has enabled more patients to adopt the treatment. However, the stringent government regulations regarding the approval of equipment have been impeding their penetration in many economies. Market players are consistently working on enhancing the operational abilities of radiotherapy equipment with digital and automated advancements and are maintaining the utmost quality care to ensure fast product approval. Moreover, exponential private-public investments in cancer treatment R&D are expected to encourage the development of new treatment equipment.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.76 billion |
Estimated Year [2024] | USD 8.28 billion |
Forecast Year [2030] | USD 12.55 billion |
CAGR (%) | 7.11% |
Type: Ongoing advancements in particle therapy systems to deliver more precise radiation therapy
External beam radiotherapy (EBRT) is a non-invasive method for providing high doses of radiation to tumors from outside the body. Conventional Cobalt-60 teletherapy units are one of the earliest forms of external beam radiotherapy equipment used in the treatment of cancer. These units operate by using gamma rays emitted from a radioactive Cobalt-60 source to destroy cancerous tissues. Linear accelerators, referred to as linacs, are the modern external beam radiotherapy. Linear accelerators deliver high-energy X-rays and electrons to the region of the patient's tumor. These devices are highly versatile, permitting a considerable degree of precision and control over the radiation dose delivered, which can be modulated to conform to the three-dimensional shape of the tumor. Particle therapy systems represent a cutting-edge and sophisticated subset of external beam radiotherapy that uses particles such as protons and heavy ions instead of X-rays to treat cancer. These systems, including proton therapy and carbon ion therapy, allow for precise delivery of radiation with a distinct physical advantage known as the Bragg peak, where the maximum energy release occurs just before the particles come to a stop within the tissue. Internal beam radiotherapy involves placing radiation sources inside and adjacent to the tumor itself. This type of therapy is necessary when a high dose of radiation is required directly at the tumor site, which is often used in the treatment of prostate, cervical, and breast cancers. Afterloaders play a pivotal role in brachytherapy, a type of internal beam radiotherapy. These sophisticated devices allow for the precise placement of radioactive sources within or adjacent to the tissue requiring treatment while minimizing exposure to healthcare personnel. Applicators are vital instruments used in brachytherapy to position radioactive sources at the treatment site. These tools come in various shapes and sizes, tailored to specific body sites and treatment protocols. Intraoperative radiotherapy systems are cutting-edge devices used to provide radiation to a tumor site during surgery. IORT systems allow for direct radiation delivery after the tumor is removed, while the surrounding healthy tissue can be temporarily displaced and protected. Seeds refer to tiny radioactive implants used in a form of brachytherapy called seed implantation. These seeds are implanted directly into the prostate gland, emitting a continuous but diminishing dose of radiation over time to destroy cancer cells.
Application: Increasing prevalence of breast cancer drives the deployment of radiation therapy equipment
In the treatment of blood cancers such as lymphoma, leukemia, and myeloma, radiation therapy can be used to destroy cancerous cells in the bone marrow, spleen, and other areas where the disease has spread. It can be used before a stem cell transplant to prepare the body to receive new blood-forming cells. Radiation therapy is a mainstay in breast cancer treatment. Post-surgery, it can be used to destroy any remaining tumor cells in the breast, chest wall, and axilla. In certain cases, it can be employed prior to surgery to shrink tumors and used palliatively to relieve symptoms of advanced cancer. For gastrointestinal cancers, including cancer of the stomach, colon, rectum, and pancreas, radiation therapy can be applied externally and internally. It is often used preoperatively to reduce tumor size and postoperatively to target residual cancer cells. It can also be essential for palliative care to alleviate pain, bleeding, and blockages. Radiation therapy for prostate cancer can be delivered through external beam radiation and brachytherapy. It can serve as a primary treatment and be used after surgery to treat remaining cancer. Advanced techniques such as image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) allow for more precise targeting, minimizing damage to surrounding tissues. For lung and other respiratory cancers, radiation therapy can be a primary treatment and combined with other modalities. It is effective in managing small-cell and non-small-cell lung cancers, particularly for patients who cannot undergo surgery. Stereotactic body radiation therapy is a developed form offering high-precision treatment for smaller lung tumors. Radiation therapy is useful in treating squamous cell carcinoma and basal cell carcinoma, a type of skin cancer. It is a non-invasive remedy option that can be considered if surgery is not preferred and if the patient has other health issues that make surgery risky. Radiation therapy can be a curative treatment or used to relieve symptoms in advanced cancers. In non-cancer applications, radiation therapy equipment is used in the treatment of benign diseases, such as thyrotoxicosis and certain inflammatory disorders. The preference for radiation therapy in non-cancer treatments is based on the targeted action and capability to provide a non-invasive treatment option that can replace surgery and pharmacological interventions in some cases.
End-User: Hospitals prioritize versatile and high-throughput systems due to their large patient base
Hospitals represent the largest end-user segment for radiation therapy equipment. They often require a broad range of radiation therapy solutions to cater to diverse patient needs. Hospitals benefit from having different types of radiation therapy equipment, such as linear accelerators, proton therapy systems, and brachytherapy systems, to provide comprehensive cancer treatment services. Specialty clinics often focus on treating specific types of cancers and, as such, require specialized radiation therapy equipment tailored to their particular needs. The preference for these clinics includes equipment that is optimized for the treatment of specific cancer types, is cost-effective for lower patient volumes, and can be easily integrated into smaller clinical settings.
Regional Insights
The Americas region observes an advanced market for radiation therapy equipment supported by the presence of established players offering highly automated equipment and developed cancer care infrastructure. The U.S. and Canada have expanded the provision of reimbursements for cancer care, which has enabled patients to access quality care with different equipment. The Asia-Pacific region observes a high prevalence of cancer cases, and medical institutes are constantly conducting R&D studies to develop improved therapies, which require new equipment. The European region has the presence of the most well-recognized players, with years of experience in offering radiotherapy equipment. Several government initiatives and awareness programs for cancer treatment have expanded the patient preference for surgeries in the early stages. The European Medical Agency and the U.S. Food and Drug Administration provide strict guidelines regarding the approval and marketing of radiotherapy equipment. However, in recent years, players have been able to achieve commercialization authorization in these countries for products that can be essential in cancer treatment.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Radiation Therapy Equipment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radiation Therapy Equipment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Radiation Therapy Equipment Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Allengers Medical Systems Ltd, BEBIG Medical GmbH, Bionix LLC, BrainLab AG, Canon Inc., Carl Zeiss AG, Eckert and Ziegler AG, Elekta AB, GE HealthCare Technologies Inc., Hitachi, Ltd., IntraOp Medical Corp., Ion Beam Applications S.A., Klarity Medical & Equipment (GZ) Co., Ltd., LINEV Group, Mevion Medical Systems, Inc., MinXray, Inc., Mitsubishi Heavy Industries, Ltd., Nordion by Sotera Health LLC, Oraya Therapeutics Inc., PTW Freiburg GmbH, RefleXion Medical, Inc., Royal Philips, Siemens Healthineers AG, Stryker Corporation, Sumitomo Heavy Industries, Ltd., and Xstrahl Group.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Radiation Therapy Equipment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radiation Therapy Equipment Market?
3. What are the technology trends and regulatory frameworks in the Radiation Therapy Equipment Market?
4. What is the market share of the leading vendors in the Radiation Therapy Equipment Market?
5. Which modes and strategic moves are suitable for entering the Radiation Therapy Equipment Market?